Advertisement
Screener

BioXcel Therapeutics, Inc. (BTAI) Effective Income Tax Rate Reconciliation, Other Adjustments, Percent

1.9 / 5 stars · 22/57 Roast Me

BioXcel Therapeutics, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Percent

BioXcel Therapeutics, Inc. (BTAI) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Percent of -0.30% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.

Financial Statements › Expense Statement › Income Tax

us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments · last filed 2025-03-28

  • BioXcel Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2024 was -0.30%.
  • BioXcel Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2023 was -0.70%, a 163.64% decline from fiscal 2022.
  • BioXcel Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2022 was 1.10%.
  • BioXcel Therapeutics, Inc. effective income tax rate reconciliation, other adjustments, percent for fiscal 2021 was -0.70%.
Period endEffective Income Tax Rate Reconciliation, Other Adjustments, Percent 12 month
2024-12-31-0.30%
10-K · filed 2025-03-28
2023-12-31-0.70%
10-K · filed 2025-03-28
2022-12-311.10%
10-K · filed 2024-03-22
2021-12-31-0.70%
10-K · filed 2023-03-16
2020-12-31-0.20%
10-K · filed 2022-03-11
2018-12-31-0.20%
10-K · filed 2020-03-09

Similar stocks

Stock NameCountryMarket CapPE Ratio
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
ORAGENICS INC (OGEN)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Nexentis Technologies Inc. (NXTS)$0.002B
Decoy Therapeutics Inc. (DCOY)United States$0.002B-0.27
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Genprex, Inc. (GNPX)United States$0.003B-0.02